Zacks Research Cuts Earnings Estimates for Merck & Co., Inc.
Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Zacks Research decreased their Q2 2025 earnings estimates for shares of Merck & Co., Inc. in a research note issued on Tuesday, June 17th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $2.03 for […]
